These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Release of endothelial microparticles in patients with arterial hypertension, hypertensive emergencies and catheter-related injury. Sansone R; Baaken M; Horn P; Schuler D; Westenfeld R; Amabile N; Kelm M; Heiss C Atherosclerosis; 2018 Jun; 273():67-74. PubMed ID: 29684662 [TBL] [Abstract][Full Text] [Related]
12. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. Koga H; Sugiyama S; Kugiyama K; Watanabe K; Fukushima H; Tanaka T; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H J Am Coll Cardiol; 2005 May; 45(10):1622-30. PubMed ID: 15893178 [TBL] [Abstract][Full Text] [Related]
13. Increased circulating CD31+/CD42b-EMPs in Perthes disease and inhibit HUVECs angiogenesis via endothelial dysfunction. Li B; Huang Q; Lin C; Lu R; Wang T; Chen X; Liu Z; Liu Y; Wu J; Wu Y; Liao S; Ding X Life Sci; 2021 Jan; 265():118749. PubMed ID: 33220290 [TBL] [Abstract][Full Text] [Related]
14. Marathon running increases circulating endothelial- and thrombocyte-derived microparticles. Schwarz V; Düsing P; Liman T; Werner C; Herm J; Bachelier K; Krüll M; Brechtel L; Jungehulsing GJ; Haverkamp W; Böhm M; Endres M; Haeusler KG; Laufs U Eur J Prev Cardiol; 2018 Feb; 25(3):317-324. PubMed ID: 29183152 [TBL] [Abstract][Full Text] [Related]
15. Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation. Fink K; Feldbrügge L; Schwarz M; Bourgeois N; Helbing T; Bode C; Schwab T; Busch HJ Crit Care; 2011; 15(5):R251. PubMed ID: 22027379 [TBL] [Abstract][Full Text] [Related]
16. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis. Berezin AE; Kremzer AA; Berezina TA; Martovitskaya YV Acta Clin Belg; 2016 Feb; 71(1):38-45. PubMed ID: 27075791 [TBL] [Abstract][Full Text] [Related]
17. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility. Takahashi T; Kobayashi S; Fujino N; Suzuki T; Ota C; He M; Yamada M; Suzuki S; Yanai M; Kurosawa S; Yamaya M; Kubo H Thorax; 2012 Dec; 67(12):1067-74. PubMed ID: 22843558 [TBL] [Abstract][Full Text] [Related]
18. Dynamic release and clearance of circulating microparticles during cardiac stress. Augustine D; Ayers LV; Lima E; Newton L; Lewandowski AJ; Davis EF; Ferry B; Leeson P Circ Res; 2014 Jan; 114(1):109-13. PubMed ID: 24141170 [TBL] [Abstract][Full Text] [Related]
19. Endothelial Cell-Derived Microparticles from Patients with Obstructive Sleep Apnea Hypoxia Syndrome and Coronary Artery Disease Increase Aortic Endothelial Cell Dysfunction. Jia L; Fan J; Cui W; Liu S; Li N; Lau WB; Ma X; Du J; Nie S; Wei Y Cell Physiol Biochem; 2017; 43(6):2562-2570. PubMed ID: 29130961 [TBL] [Abstract][Full Text] [Related]
20. Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD. Tőkés-Füzesi M; Ruzsics I; Rideg O; Kustán P; Kovács GL; Molnár T Int J Chron Obstruct Pulmon Dis; 2018; 13():3749-3757. PubMed ID: 30532530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]